User profiles for "author:S Manolakopoulos"
 | Spilios ManolakopoulosAssociate Professor in Medicine-Gastroenterology, National and Kapodistrian University of … Verified email at med.uoa.gr Cited by 8151 |
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
…, A Largen, M Makara, S Manolakopoulos… - Liver …, 2011 - Wiley Online Library
Abstract Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country …
epidemiological data. A comprehensive review of the literature was used to gather country …
[HTML][HTML] Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos (t) ide therapy: a systematic review
…, P Lampertico, S Manolakopoulos… - Journal of …, 2010 - Elsevier
Background & Aims: Chronic hepatitis B patients are at increased risk for hepatocellular
carcinoma (HCC). The effect of medium-term nucleos (t) ide analogue therapy on HCC …
carcinoma (HCC). The effect of medium-term nucleos (t) ide analogue therapy on HCC …
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
GV Papatheodoridis, S Manolakopoulos… - The Lancet infectious …, 2008 - thelancet.com
Currently available options for the treatment of chronic hepatitis B virus (HBV) infection
include standard and pegylated interferon alfa and four oral antiviral agents (lamivudine …
include standard and pegylated interferon alfa and four oral antiviral agents (lamivudine …
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
…, J Goulis, JL Calleja, H Chi, S Manolakopoulos… - Journal of …, 2016 - Elsevier
Background & Aims Risk scores for hepatocellular carcinoma (HCC) developed in Asians
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
Whether there is a change of hepatocellular carcinoma (HCC) incidence in chronic hepatitis
B patients under long‐term therapy with potent nucleos (t) ide analogues is currently …
B patients under long‐term therapy with potent nucleos (t) ide analogues is currently …
Large balloon dilation vs. mechanical lithotripsy for the management of large bile duct stones: a prospective randomized study
…, N Viazis, D Pleskow, S Manolakopoulos… - Official journal of the …, 2011 - journals.lww.com
OBJECTIVES: The removal of large bile duct stones (> 12 mm) after endoscopic
sphincterotomy (EST) remains a challenging issue in therapeutic endoscopy. The aim of this …
sphincterotomy (EST) remains a challenging issue in therapeutic endoscopy. The aim of this …
Intestinal decontamination improves liver haemodynamics in patients with alcohol‐related decompensated cirrhosis
…, K Foudoulis, S Manolakopoulos… - Alimentary …, 2009 - Wiley Online Library
Background Endotoxaemia is commonly seen in cirrhotic patients with ascites and this may
be associated with increased portal pressure. Aim To investigate the effect of intestinal …
be associated with increased portal pressure. Aim To investigate the effect of intestinal …
[PDF][PDF] Outcome of hepatitis B e antigen–negative chronic hepatitis B on long‐term nucleos (t) ide analog therapy starting with lamivudine
…, E Dimou, K Dimakopoulos, S Manolakopoulos… - …, 2005 - Wiley Online Library
We determined the clinical outcome of hepatitis e antigen (HBeAg)‐negative chronic
hepatitis B patients treated with long‐term nucleos (t) ide analog therapy starting with …
hepatitis B patients treated with long‐term nucleos (t) ide analog therapy starting with …
[HTML][HTML] Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review
GV Papatheodoridis, S Manolakopoulos, YF Liaw… - Journal of …, 2012 - Elsevier
BACKGROUND & AIMS: The adequacy of monitoring HBeAg-negative patients based on
ALT activity is controversial and current guidelines favor liver biopsy in HBeAg-negative …
ALT activity is controversial and current guidelines favor liver biopsy in HBeAg-negative …
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral …
Objective To evaluate the risk and predictors of hepatocellular carcinoma (HCC) in HBeAg-
negative chronic hepatitis B patients of the large HEPNET. Greece cohort study who …
negative chronic hepatitis B patients of the large HEPNET. Greece cohort study who …